Abingdon Health Plc
ABDXF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 51.7% | 42.7% | -75.6% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 60% | 51.3% | -184.4% | 29.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14.9% | -78.4% | -701.5% | -41.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.7% | -85.8% | -750% | -60% |
| EPS Diluted | -0.004 | -0.011 | -0.073 | -0.073 |
| % Growth | 63.2% | 84.4% | -0.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |